The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Sustained action is needed now if we are to capitalise on the opportunity to eliminate viral hepatitis by 2030.
On International Safe Abortion Day (28 September), we give an overview of the link between HIV and abortion and the need for broader sexual reproductive health rights for women.
Getting on top of the tuberculosis epidemic requires renewed attention, and bringing HIV out of isolation.
Opportunities to increase access to the hepatitis C cure exist – but strong political will is needed and many countries are failing to benefit from cheaper generics.
In their first treatment update since 2016, the World Health Organization (WHO) adopts a ‘treat all’ approach for hepatitis C, guided by the success of the HIV treatment experience.
Despite the huge human and economic toll, research into hepatitis B remains drastically underfunded, and was recently alikened to a neglected tropical disease. But hope for a cure is growing.
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.
First update on cryptococcus in the era of antiretroviral treatment expansion reveals disproportionate burden in sub-Saharan Africa and a need for better treatment options.
Progress in halting TB – the world’s leading infectious disease killer – is plagued by a lack of political will and inequalities in healthcare access
Cryptococcal meningitis (crypto) may not be the first thing that comes to mind when talking about HIV – but this common opportunistic infection and AIDS-defining illness is one of the leading killers of people living with HIV globally.
